PD Neurotechnology Ltd
- Industry
- Medical Devices & Equipment
- Founded Year
- 2015
- Headquarters
- London, United Kingdom
- Employee Count
- 25
Key People
- Nikolaos Moschos - CEO
- Anastasios Manos - Founder & Partner
- Spyridon Konitsiotis - Founder & Medical Director
- Dimitris Fotiadis - Founder & Technical Director
Assessment
- Team
-
Aspect: Multiple successful MedTech entrepreneurs
Summary: The founding team comprises experienced professionals with backgrounds in medical technology and patient monitoring systems.
The founders' prior successes in MedTech provide a strong foundation for PD Neurotechnology's endeavors.
- Clinical Need
-
Aspect: Very Strong
Summary: PDMonitor addresses a significant gap in continuous monitoring for Parkinson's disease, enhancing patient care.
Continuous symptom monitoring is essential for effective treatment, and PDMonitor fulfills this need effectively.
- Competition
-
Aspect: First mover
Summary: PD Neurotechnology is among the first to offer a comprehensive wearable solution for Parkinson's monitoring.
While pioneering, the company must invest in educating the market and establishing trust in their technology.
- Technical Challenge
-
Aspect: Moderate
Summary: Developing accurate, non-invasive monitoring devices involves moderate technical challenges.
Ensuring the device's precision in symptom detection is crucial for clinical acceptance and patient trust.
- Patent
-
Aspect: Strong
Summary: The company holds strong patents protecting its technology and methodologies.
Patents deter competitors and can enhance the company's valuation and attractiveness to investors.
- Financing
-
Aspect: Well-funded
Summary: PD Neurotechnology has secured significant funding, including a 2.7M round in April 2023.
The recent funding round indicates investor confidence and provides resources for scaling operations.
- Regulatory
-
Aspect: 510k/PMA
Summary: The company has obtained necessary certifications, including ISO standards, indicating regulatory compliance.
Compliance with international standards ensures product safety and efficacy, essential for adoption in medical settings.
Opportunity Rollup
- Odds of Success
- 3.2
- Peak Market Share
- 3.8
- Segment CAGR
- 4.9%
- Market Segment
- Neurology Devices
- Market Sub Segment
- Patient Monitoring
| Year Post Launch | Market Penetration (%) |
|---|---|
| 1 | 0.19 |
| 2 | 0.57 |
| 3 | 1.33 |
| 4 | 2.66 |
| 5 | 3.80 |
Key Takeaway
PD Neurotechnology's innovative PDMonitor addresses a critical need in Parkinson's care, supported by a strong team and adequate funding, positioning the company well in a growing market.